PD‐1 is highly expressed by neoplastic B‐cells in Richter transformation
Open Access
- 20 July 2018
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 185 (2), 370-373
- https://doi.org/10.1111/bjh.15514
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLLBlood, 2017
- An update for Richter syndrome – new directions and developmentsBritish Journal of Haematology, 2017
- Human regulatory B cells in health and disease: therapeutic potentialJCI Insight, 2017
- PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomasNature Reviews Clinical Oncology, 2016
- Coinhibitory Pathways in Immunotherapy for CancerAnnual Review of Immunology, 2016
- PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease ProgressionCancer Discovery, 2016
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorHaematologica, 2010
- CD1d is expressed on B‐chronic lymphocytic leukemia cells and mediates α‐galactosylceramide presentation to natural killer T lymphocytesInternational Journal of Cancer, 2004
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood, 2004